GUBRFGUBRA A S

About GUBRA A S (GUBRF)

GUBRA A S (GUBRF) is a N/A company headquartered in Horsholm, Denmark whose shares trade over-the-counter on the Pink tier.

Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs in Denmark and internationally. The company operates through CRO, Discovery & Partnerships, and Gubra Green segments. It offers pre-clinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry, as well as provides services in vivo pharmacology, assays and molecular pharmacology, bioinformatics, bioanalysis, next gen sequencing, and 2D and 3D imaging. The company has a partnership and collaboration with Boehringer Ingelheim to discover novel peptides for the treatment of obesity.

GUBRF key facts

Ticker symbol

GUBRF

Market tier

Pink

Headquarters

Horsholm, Denmark

Estimated market cap

$912.52M (as of May 12, 2025)

Shares outstanding

15,170,733

Reporting standard

International Reporting: Nasdaq OMX Nordic Exchange Copenhagen

Audit status

Audited

Fiscal year end

12/31

Explore more: Pink stocks · OTC stocks starting with G